Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Saved in:
| Title: | Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. |
|---|---|
| Authors: | Rudick RA (AUTHOR), Stuart WH (AUTHOR), Calabresi PA (AUTHOR), Confavreux C (AUTHOR), Galetta SL (AUTHOR), Radue E (AUTHOR), Lublin FD (AUTHOR), Weinstock-Guttman B (AUTHOR), Wynn DR (AUTHOR), Lynn F (AUTHOR), Panzara MA (AUTHOR), Sandrock AW (AUTHOR), SENTINEL Investigators (CORPORATE AUTHOR) |
| Source: | New England Journal of Medicine. 3/2/2006, Vol. 354 Issue 9, p911-923. 13p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 106338783 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Rudick+RA%22">Rudick RA</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stuart+WH%22">Stuart WH</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Calabresi+PA%22">Calabresi PA</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Confavreux+C%22">Confavreux C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Galetta+SL%22">Galetta SL</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Radue+E%22">Radue E</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lublin+FD%22">Lublin FD</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Weinstock-Guttman+B%22">Weinstock-Guttman B</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wynn+DR%22">Wynn DR</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lynn+F%22">Lynn F</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Panzara+MA%22">Panzara MA</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sandrock+AW%22">Sandrock AW</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22SENTINEL+Investigators%22">SENTINEL Investigators</searchLink> (CORPORATE AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22New+England+Journal+of+Medicine%22">New England Journal of Medicine</searchLink>. 3/2/2006, Vol. 354 Issue 9, p911-923. 13p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=106338783 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 911 Titles: – TitleFull: Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rudick RA – PersonEntity: Name: NameFull: Stuart WH – PersonEntity: Name: NameFull: Calabresi PA – PersonEntity: Name: NameFull: Confavreux C – PersonEntity: Name: NameFull: Galetta SL – PersonEntity: Name: NameFull: Radue E – PersonEntity: Name: NameFull: Lublin FD – PersonEntity: Name: NameFull: Weinstock-Guttman B – PersonEntity: Name: NameFull: Wynn DR – PersonEntity: Name: NameFull: Lynn F – PersonEntity: Name: NameFull: Panzara MA – PersonEntity: Name: NameFull: Sandrock AW – PersonEntity: Name: NameFull: SENTINEL Investigators IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 03 Text: 3/2/2006 Type: published Y: 2006 Identifiers: – Type: issn-print Value: 00284793 Numbering: – Type: volume Value: 354 – Type: issue Value: 9 Titles: – TitleFull: New England Journal of Medicine Type: main |
| ResultId | 1 |
